Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions

Hepatology

Volumn 56, Issue 4, 2012, Pages 1391-1400

  Kremer, Andreas E ^a,b   van Dijk, Remco ^a   Leckie, Pamela ^c   Schaap, Frank G ^a   Kuiper, Edith M M ^d   Mettang, Thomas ^e   Reiners, Katrin S ^f   Raap, Ulrike ^g   van Buuren, Henk R ^d   van Erpecum, Karel J ^h   Davies, Nathan A ^c   Rust, Christian ⁱ   Engert, Andreas ^f   Jalan, Rajiv ^c   Oude Elferink, Ronald P J ^a   Beuers, Ulrich ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^f UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTAXIN; BILE SALT; COLESEVELAM; FIBROBLAST GROWTH FACTOR 19; PLACEBO; RIFAMPICIN;

ARTICLE; ATOPIC DERMATITIS; BILIARY TRACT DRAINAGE; BLOOD SAMPLING; CELL STRAIN HEPG2; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEPATOMA CELL; HODGKIN DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PRURITUS; TREATMENT RESPONSE; UREMIA;

ALLYLAMINE; ANALYSIS OF VARIANCE; ANTIPRURITICS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHOLESTASIS; COHORT STUDIES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBROBLAST GROWTH FACTORS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; LYSOPHOSPHOLIPASE; MALE; MULTIVARIATE ANALYSIS; PHOSPHORIC DIESTER HYDROLASES; POLYMERASE CHAIN REACTION; PRURITUS; RIFAMPIN; ROC CURVE; TREATMENT OUTCOME;

EID: 84864357786     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25748     Document Type: Article

References (26)

1. Ikoma A, Steinhoff M, Stander S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat Rev Neurosci 2006; 7: 535-547.
2. Kremer AE, Beuers U, Oude-Elferink RP, Pusl T. Pathogenesis and treatment of pruritus in cholestasis. Drugs 2008; 68: 2163-2182.
3. Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 318-328.
4. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol 2009; 51: 237-267.
5. Pares A, Herrera M, Aviles J, Sanz M, Mas A. Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. J Hepatol 2010; 53: 307-312.
6. Stapelbroek JM, van Erpecum KJ, Klomp LW, Venneman NG, Schwartz TP, van Berge Henegouwen GP, et al. Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis. HEPATOLOGY 2006; 43: 51-53.
7. Beuers U, Gerken G, Pusl T. Biliary drainage transiently relieves intractable pruritus in primary biliary cirrhosis. HEPATOLOGY 2006; 44: 280-281.
8. Kremer AE, Martens JJ, Kulik W, Rueff F, Kuiper EM, van Buuren HR, et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 2010; 139: 1008-1018.
9. Nakanaga K, Hama K, Aoki J. Autotaxin-an LPA producing enzyme with diverse functions. J Biochem 2010; 148: 13-24.
10. van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradere JP, et al. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 2006; 26: 5015-5022.
11. Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 2003; 3: 582-591.
12. Kuiper EM, van Erpecum KJ, Beuers U, Hansen BE, Thio HB, de Man RA, et al. The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. HEPATOLOGY 2010; 52: 1334-1340.
13. Nibourg GA, Huisman MT, van der Hoeven TV, van Gulik TM, Chamuleau RA, Hoekstra R. Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application. Liver Transpl 2010; 16: 1075-1085.
14. Schaap FG, van der Gaag NA, Gouma DJ, Jansen PL. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. HEPATOLOGY 2009; 49: 1228-1235.
15. Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, et al. Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 2006; 281: 25822-25830.
16. Leckie P, Tritto G, Proven A, Cheshire L, Mookerjee RP, Jones DE, et al. "Outpatient" albumin dialysis for intractable itch in chronic cholestatic liver disease patients is a feasible, safe, and efficacious alternative to liver transplantation HEPATOLOGY 2009; 50: 376A.
17. Nakamura K, Ohkawa R, Okubo S, Tozuka M, Okada M, Aoki S, et al. Measurement of lysophospholipase D/autotaxin activity in human serum samples. Clin Biochem 2007; 40: 274-277.
18. Jansen S, Andries M, Vekemans K, Vanbilloen H, Verbruggen A, Bollen M. Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett 2009; 284: 216-221.
19. Weisshaar E, Dalgard F. Epidemiology of itch: adding to the burden of skin morbidity. Acta Derm Venereol 2009; 89: 339-350.
20. Zirwas MJ, Seraly MP. Pruritus of unknown origin: a retrospective study. J Am Acad Dermatol 2001; 45: 892-896.
21. Sommer F, Hensen P, Bockenholt B, Metze D, Luger TA, Stander S. Underlying diseases and co-factors in patients with severe chronic pruritus: a 3-year retrospective study. Acta Derm Venereol 2007; 87: 510-516.
22. Eisendle K, Muller H, Ortner E, Talasz H, Graziadei I, Vogel W, et al. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease. J Gastroenterol Hepatol 2011; 26: 716-721.
23. Masuda A, Nakamura K, Izutsu K, Igarashi K, Ohkawa R, Jona M, et al. Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol 2008; 143: 60-70.
24. Sasagawa T, Suzuki K, Shiota T, Kondo T, Okita M. The significance of plasma lysophospholipids in patients with renal failure on hemodialysis. J Nutr Sci Vitaminol (Tokyo) 1998; 44: 809-818.
25. Tsutsumi T, Adachi M, Nikawadori M, Morishige J, Tokumura A. Presence of bioactive lysophosphatidic acid in renal effluent of rats with unilateral ureteral obstruction. Life Sci 2011; 89: 195-203.
26. Kremer AE, Oude Elferink RP, Beuers U. Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol 2011; 35: 89-97.